tradingkey.logo

Cooper Companies Inc

COO
View Detailed Chart
74.890USD
-0.110-0.15%
Market hours ETQuotes delayed by 15 min
14.89BMarket Cap
36.51P/E TTM

Cooper Companies Inc

74.890
-0.110-0.15%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.15%

5 Days

+5.17%

1 Month

+9.86%

6 Months

-4.84%

Year to Date

-18.54%

1 Year

-29.83%

View Detailed Chart

TradingKey Stock Score of Cooper Companies Inc

Currency: USD Updated: 2025-10-21

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Cooper Companies Inc's Score

Industry at a Glance

Industry Ranking
33 / 204
Overall Ranking
90 / 4687
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 21 analysts
Buy
Current Rating
83.797
Target Price
+11.74%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Cooper Companies Inc Highlights

StrengthsRisks
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 17.74% year-on-year.
Overvalued
The company’s latest PE is 36.68, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 204.94M shares, decreasing 2.77% quarter-over-quarter.
Held by Larry Robbins
Star Investor Larry Robbins holds 280.69K shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Cooper Companies Inc Info

The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Ticker SymbolCOO
CompanyCooper Companies Inc
CEOMr. Albert G. White, III
Websitehttps://www.coopercos.com/
KeyAI